Journal of Nephrology

, Volume 27, Issue 4, pp 361–370 | Cite as

Renal outcomes of bariatric surgery in obese adults with diabetic kidney disease

  • Bhavana B. Rao
  • Abhik Bhattacharya
  • Varun Agrawal
Review

Abstract

Obesity is a pandemic with several significant adverse health outcomes. Chronic kidney disease has been an overlooked consequence of obesity. Among diabetics, obesity is known to amplify the risk for kidney disease. Although bariatric surgery promises significant and sustained weight reduction with favorable impact on metabolic parameters such as glycemic control, hypertension and dyslipidemia, its impact on the renal complications of diabetes is poorly understood. This paper aims to comprehensively evaluate the evidence in the published literature on the impact of bariatric surgery on renal outcomes in obese adults with diabetic kidney disease. While many observational studies have demonstrated significant reduction in proteinuria after bariatric surgery, there is paucity of data regarding changes in renal filtration function such as doubling of serum creatinine or progression to end stage kidney disease. No randomized controlled trials comparing medical vs. surgical therapy in obese adults with diabetic kidney disease exist, hence assessing the metabolic benefits vs. the surgical risks is important before recommending bariatric surgery to this growing patient population. Future studies require a collaborative effort between bariatric surgeons and nephrologists to measure long-term effects of bariatric surgery on renal outcomes incorporating evolving markers of kidney injury to advance this field.

Keywords

Diabetic nephropathy Bariatric surgery Obesity 

References

  1. 1.
    Wiggins KJ, Johnson DW (2005) The influence of obesity on the development and survival outcomes of chronic kidney disease. Adv Chronic Kidney Dis 12(1):49–55PubMedCrossRefGoogle Scholar
  2. 2.
    Herrera-Valdes R, Almaguer M, Chipi J, Toirac X, Martinez O, Castellanos O et al (2008) Prevalence of obesity and its association with chronic kidney disease, hypertension and diabetes mellitus. Isle of Youth Study (ISYS), Cuba. MEDICC review 10(2):14–20 [Epub 2008/04/01]Google Scholar
  3. 3.
    Wahba IM, Mak RH (2007) Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. CJASN 2(3):550–562 [Epub 2007/08/19]PubMedGoogle Scholar
  4. 4.
    Tanner RM, Brown TM, Muntner P (2012) Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Curr Hypertens Rep 14(2):152–159 [Epub 2012/02/10]PubMedCrossRefGoogle Scholar
  5. 5.
    Bult MJ, van Dalen T, Muller AF (2008) Surgical treatment of obesity. European journal of endocrinology/European Federation of Endocrine Societies. 158(2):135–145 [Epub 2008/01/31]PubMedCrossRefGoogle Scholar
  6. 6.
    Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366(17):1577–1585 [Epub 2012/03/28]PubMedCrossRefGoogle Scholar
  7. 7.
    Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567–1576 [Epub 2012/03/28]PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    KDOQI (2007) KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49(2 Suppl 2):S12–154. [Epub 2007/02/06]Google Scholar
  9. 9.
    Agrawal V, Kizilbash SH, McCullough PA (2008) New therapeutic agents for diabetic kidney disease. Therapy 5(4):553–575CrossRefGoogle Scholar
  10. 10.
    Thomson SC, Vallon V, Blantz RC (2004) Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 286(1):F8–F15PubMedCrossRefGoogle Scholar
  11. 11.
    Leon CA, Raij L (2005) Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy. J Hypertens 23(11):1931–1937PubMedCrossRefGoogle Scholar
  12. 12.
    Caramori ML, Mauer M (2003) Diabetes and nephropathy. Curr Opin Nephrol Hypertens 12(3):273–282PubMedCrossRefGoogle Scholar
  13. 13.
    Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O (2006) Obesity and risk for chronic renal failure. JASN 17(6):1695–1702PubMedCrossRefGoogle Scholar
  14. 14.
    Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144(1):21–28PubMedCrossRefGoogle Scholar
  15. 15.
    de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL (2002) Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 26(4):S21–S24PubMedCrossRefGoogle Scholar
  16. 16.
    Savage S, Nagel NJ, Estacio RO, Lukken N, Schrier RW (1995) Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis 25(6):836–844PubMedCrossRefGoogle Scholar
  17. 17.
    Ferris M, Hogan SL, Chin H, Shoham DA, Gipson DS, Gibson K et al (2007) Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. CJASN 2(6):1207–1214 [Epub 2007/10/19]PubMedGoogle Scholar
  18. 18.
    Praga M, Morales E (2006) Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens 15(5):481–486PubMedCrossRefGoogle Scholar
  19. 19.
    Rutkowski P, Klassen A, Sebekova K, Bahner U, Heidland A (2006) Renal disease in obesity: the need for greater attention. J Renal Nutr 16(3):216–223 [Epub 2006/07/11]CrossRefGoogle Scholar
  20. 20.
    Praga M (2002) Obesity: a neglected culprit in renal disease. Nephrol Dial Transplant 17(7):1157–1159PubMedCrossRefGoogle Scholar
  21. 21.
    Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U (2000) Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 278(5):F817–F822PubMedGoogle Scholar
  22. 22.
    Kasiske BL, Napier J (1985) Glomerular sclerosis in patients with massive obesity. Am J Nephrol 5(1):45–50 [Epub 1985/01/01]PubMedCrossRefGoogle Scholar
  23. 23.
    Flatt PR, Day C, Bailey CJ (2009) Review: bariatric surgery: to treat diabesity. Br J Diabetes Vasc Dis 9(3):103–107CrossRefGoogle Scholar
  24. 24.
    Chen H-M, Liu Z-H, Zeng C-H, Li S-J, Wang Q-W, Li L-S (2006) Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis 48(5):772–779PubMedCrossRefGoogle Scholar
  25. 25.
    Sarafidis PA, Ruilope LM (2006) Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 26(3):232–244PubMedCrossRefGoogle Scholar
  26. 26.
    Sugerman HJ (2001) Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am 81(5):1063–75, vi. [Epub 2001/10/09]Google Scholar
  27. 27.
    Bloomfield GL, Blocher CR, Fakhry IF, Sica DA, Sugerman HJ (1997) Elevated intra-abdominal pressure increases plasma renin activity and aldosterone levels. J Trauma 42(6):997–1004. (discussion-5). [Epub 1997/06/01]Google Scholar
  28. 28.
    Agrawal V, Shah A, Rice C, Franklin BA, McCullough PA (2009) Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol 5(9):520–528 [Epub 2009/07/29]PubMedCrossRefGoogle Scholar
  29. 29.
    Hajer GR, van Haeften TW, Visseren FL (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29(24):2959–2971 [Epub 2008/09/09]PubMedCrossRefGoogle Scholar
  30. 30.
    Praga M, Hernandez E, Andres A, Leon M, Ruilope LM, Rodicio JL (1995) Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 70(1):35–41PubMedCrossRefGoogle Scholar
  31. 31.
    Carlyle M, Jones OB, Kuo JJ, Hall JE (2002) Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 39(2 Pt 2):496–501PubMedCrossRefGoogle Scholar
  32. 32.
    Ix JH, Sharma K (2010) Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. JASN 21(3):406–412PubMedCrossRefGoogle Scholar
  33. 33.
    Serra A, Granada ML, Romero R, Bayes B, Canton A, Bonet J et al (2006) The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr (Edinburgh, Scotland) 25(3):400–8. [Epub 2006/05/20]Google Scholar
  34. 34.
    Yano Y, Hoshide S, Ishikawa J, Hashimoto T, Eguchi K, Shimada K et al (2007) Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes. Journal of clinical hypertension (Greenwich, Conn) 9(10):775–82. [Epub 2007/10/06]Google Scholar
  35. 35.
    Cannon CP, Kumar A (2009) Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options. Clin Cornerstone 9(4):55–68. (discussion 9–71). [Epub 2009/10/01]Google Scholar
  36. 36.
    Maric C, Hall JE (2011) Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol 170:28–35 [Epub 2011/06/11]PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Griffin KA, Kramer H, Bidani AK (2008) Adverse renal consequences of obesity. Am J Physiol Renal Physiol 294(4):F685–F696 [Epub 2008/02/01]PubMedCrossRefGoogle Scholar
  38. 38.
    Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. JASN 15(1):S55–S57PubMedCrossRefGoogle Scholar
  39. 39.
    King GL (2008) The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79(8 Suppl):1527–1534PubMedCrossRefGoogle Scholar
  40. 40.
    Luk AO, So WY, Ma RC, Kong AP, Ozaki R, Ng VS et al (2008) Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 31(12):2357–2361 [Epub 2008/10/07]PubMedCentralPubMedCrossRefGoogle Scholar
  41. 41.
    Lamacchia O, Nicastro V, Camarchio D, Stallone G, Gesualdo L, Cignarelli M (2008) Waist circumference is strongly associated with renal resistive index in normoalbuminuric patients with type 2 diabetes. Am J Nephrol 28(1):54–58 [Epub 2007/09/29]PubMedCrossRefGoogle Scholar
  42. 42.
    Lamacchia O, Nicastro V, Camarchio D, Valente U, Grisorio R, Gesualdo L et al (2010) Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricemia in type-2 diabetic patients. Nephrol Dial TransplantGoogle Scholar
  43. 43.
    Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D et al (2008) Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association 23(4):1278–84. [Epub 2007/11/28]Google Scholar
  44. 44.
    Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23(4):427–436 [Epub 2013/01/23]PubMedCrossRefGoogle Scholar
  45. 45.
    Friedman MN, Sancetta AJ, Magovern GJ (1955) The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet 100(2):201–204 [Epub 1955/02/01]PubMedGoogle Scholar
  46. 46.
    de la Cruz-Muñoz N, Messiah SE, Arheart KL, Lopez-Mitnik G, Lipshultz SE, Livingstone A (2011) Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and pre-diabetes among morbidly obese multiethnic adults: long-term results. J Am Coll Surg 212(4):505–511PubMedCrossRefGoogle Scholar
  47. 47.
    Nocca D, Guillaume F, Noel P, Picot MC, Aggarwal R, El Kamel M et al (2011) Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year. Obes Surg 21(6):738–743 [Epub 2011/04/07]PubMedCrossRefGoogle Scholar
  48. 48.
    Mumme DE, Mathiason MA, Kallies KJ, Kothari SN (2009) Effect of laparoscopic Roux-en-Y gastric bypass surgery on hemoglobin A1c levels in diabetic patients: a matched-cohort analysis. Surg Obes Relat Dis 5(1):4–10PubMedCrossRefGoogle Scholar
  49. 49.
    Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299(3):316–323 [Epub 2008/01/24]PubMedCrossRefGoogle Scholar
  50. 50.
    Fowler S, Kon V, Ma L, Richards W, Fogo A, Hunley T (2009) Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery. Pediatr Nephrol 24(4):851–855PubMedCrossRefGoogle Scholar
  51. 51.
    Agnani S, Vachharajani VT, Gupta R, Atray NK, Vachharajani TJ (2005) Does treating obesity stabilize chronic kidney disease? BMC Nephrol 6:7 [Epub 2005/06/16]PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Navaneethan SD, Yehnert H (2009) Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis 5(6):662–665 [Epub 2009/04/11]PubMedCrossRefGoogle Scholar
  53. 53.
    Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S (2009) Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 4(10):1565–1574PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Navarro-Diaz M, Serra A, Romero R, Bonet J, Bayes B, Homs M et al (2006) Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. JASN 17(12 Suppl 3):S213–S217 [Epub 2006/11/30]PubMedCrossRefGoogle Scholar
  55. 55.
    Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y (2003) The effects of weight loss on renal function in patients with severe obesity. JASN 14(6):1480–1486 [Epub 2003/05/23]PubMedCrossRefGoogle Scholar
  56. 56.
    Alexander JW, Goodman HR, Hawver LR, Cardi MA (2009) Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis 5(2):237–241 [Epub 2008/11/11]PubMedCrossRefGoogle Scholar
  57. 57.
    Afshinnia F, Wilt TJ, Duval S, Esmaeili A, Ibrahim HN (2010) Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 25(4):1173–1183PubMedCrossRefGoogle Scholar
  58. 58.
    Izzedine H, Coupaye M, Reach I, Deray G (2005) Gastric bypass and resolution of proteinuria in an obese diabetic patient. Diabet Med 22(12):1761–1762PubMedCrossRefGoogle Scholar
  59. 59.
    Perez G, Devaud N, Escalona A, Downey P (2006) Resolution of early stage diabetic nephropathy in an obese diabetic patient after gastric bypass. Obes Surg 16(10):1388–1391 [Epub 2006/10/25]PubMedCrossRefGoogle Scholar
  60. 60.
    Czupryniak L, Wiszniewski M, Szymanski D, Pawlowski M, Loba J, Strzelczyk J (2010) Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients. Obes Surg 20(4):506–508 [Epub 2010/02/04]PubMedCrossRefGoogle Scholar
  61. 61.
    Agrawal V, Khan I, Rai B, Krause KR, Chengelis DL, Zalesin KC et al (2008) The effect of weight loss after bariatric surgery on albuminuria. Clin Nephrol 70(3):194–202 [Epub 2008/09/17]PubMedCrossRefGoogle Scholar
  62. 62.
    Saliba J, Kasim NR, Tamboli RA, Isbell JM, Marks P, Feurer ID et al (2010) Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery 147(2):282–287 [Epub 2009/12/17]PubMedCentralPubMedCrossRefGoogle Scholar
  63. 63.
    Navaneethan S, Kelly K, Sabbagh F, Schauer P, Kirwan J, Kashyap S (2010) Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg 20(3):308–315PubMedCentralPubMedCrossRefGoogle Scholar
  64. 64.
    Iaconelli A, Panunzi S, De Gaetano A, Manco M, Guidone C, Leccesi L et al (2011) Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 34(3):561–567 [Epub 2011/02/02]PubMedCentralPubMedCrossRefGoogle Scholar
  65. 65.
    Heneghan HM, Cetin D, Navaneethan SD, Orzech N, Brethauer SA, Schauer PR (2013) Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis 9(1):7–14 [Epub 2012/12/06]PubMedCrossRefGoogle Scholar
  66. 66.
    Buchwald H et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14):1724–37Google Scholar
  67. 67.
    Pang TT, Narendran P (2008) Addressing insulin resistance in type 1 diabetes. Diabet Med 25(9):1015–1024PubMedCrossRefGoogle Scholar
  68. 68.
    Bueter M, Dubb SS, Gill A, Joannou L, Ahmed A, Frankel AH et al (2010) Renal cytokines improve early after bariatric surgery. Br J Surg 97(12):1838–1844PubMedCrossRefGoogle Scholar
  69. 69.
    Knop FK (2009) Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling? Diabetologia 52(11):2270–2276 [Epub 2009/09/04]PubMedCrossRefGoogle Scholar
  70. 70.
    Vetter ML, Cardillo S, Rickels MR, Iqbal N (2009) Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 150(2):94–103 [Epub 2009/01/21]PubMedCrossRefGoogle Scholar
  71. 71.
    Mole DR, Tomson CRV, Mortensen N, Winearls CG (2001) Renal complications of jejunoileal bypass for obesity. QJM 94(2):69–77PubMedCrossRefGoogle Scholar
  72. 72.
    Semins MJ, Asplin JR, Steele K, Assimos DG, Lingeman JE, Donahue S et al (2010) The effect of restrictive bariatric surgery on urinary stone risk factors. Urology 76(4):826–829 [Epub 2010/04/13]PubMedCrossRefGoogle Scholar
  73. 73.
    Ahmed MH, Byrne CD (2010) Bariatric surgery and chronic kidney disease: an intriguing relationship. Nephrol Dial Transplant 25(12):4117–4118CrossRefGoogle Scholar
  74. 74.
    Agrawal V LX, Campfield T, Silva EJ, Romanelli J, Braden GL (2010) Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass. Surg Obes Relat DisGoogle Scholar
  75. 75.
    Nasr SH, D’Agati VD, Said SM, Stokes MB, Largoza MV, Radhakrishnan J et al (2008) Oxalate nephropathy complicating Roux-en-Y Gastric bypass: an under recognized cause of irreversible renal failure. CJASN 3(6):1676–1683 [Epub 2008/08/15]PubMedCentralPubMedGoogle Scholar
  76. 76.
    Thakar CV, Kharat V, Blanck S, Leonard AC (2007) Acute kidney injury after gastric bypass surgery. CJASN 2(3):426–430 [Epub 2007/08/19]PubMedGoogle Scholar
  77. 77.
    Sharma SK, McCauley J, Cottam D, Mattar SG, Holover S, Dallal R et al (2006) Acute changes in renal function after laparoscopic gastric surgery for morbid obesity. Surg Obes Relat Dis 2(3):389–392 [Epub 2006/08/24]PubMedCrossRefGoogle Scholar
  78. 78.
    Turgeon NA, Perez S, Mondestin M, Davis SS, Lin E, Tata S et al (2012) The impact of renal function on outcomes of bariatric surgery. JASN 23(5):885–894 [Epub 2012/03/03]PubMedCrossRefGoogle Scholar
  79. 79.
    Pories WJ (2008) Bariatric surgery: risks and rewards. J Clin Endocrinol Metab 93(11 Suppl 1):S89–S96 [Epub 2008/12/04]PubMedCentralPubMedCrossRefGoogle Scholar
  80. 80.
    Brethauer SA, Chand B, Schauer PR (2006) Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med 73(11):993–1007 [Epub 2006/11/30]PubMedCrossRefGoogle Scholar
  81. 81.
    Nguyen NT, Hinojosa M, Fayad C, Varela E, Wilson SE (2007) Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J Am Coll Surg 205(2):248–255 [Epub 2007/07/31]PubMedCrossRefGoogle Scholar
  82. 82.
    Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P et al (2009) Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 75(1):88–95 [Epub 2008/10/10]PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Nephrology 2014

Authors and Affiliations

  • Bhavana B. Rao
    • 1
  • Abhik Bhattacharya
    • 2
  • Varun Agrawal
    • 3
  1. 1.Department of Internal MedicineUniversity of Pittsburgh Medical CenterPittsburghUSA
  2. 2.Department of Internal MedicineJohn H. Stroger, Jr. Hospital of Cook CountyChicagoUSA
  3. 3.Division of Nephrology and HypertensionUniversity of Vermont College of Medicine, Fletcher Allen HealthcareBurlingtonUSA

Personalised recommendations